Transasia Bio-Medicals Ltd-医療機器分野:企業M&A・提携分析

◆英語タイトル:Transasia Bio-Medicals Ltd - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA8011336
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月22日
◆ページ数:19
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:インド
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Transasia Bio-Medicals Ltd (Transasia), a subsidiary of Erba Diagnostics Mannheim GmbH is an in-vitro diagnostic company that manufactures and exports diagnostic instruments and reagents. The company offers its products in various categories including clinical chemistry, immunology, diabetes management, urine analysis, hematology, microbiology, critical care, coagulation among others. Transasia has its manufacturing facilities in Mumbai, Daman and Baddi. The company exports its products to Italy, Germany, France, Australia, Turkey, the US, China, Latin America, Russia, and other African, the Middle East and Asian countries. Transasia is headquartered in Mumbai, Maharashtra, India.

Transasia Bio-Medicals Ltd – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Transasia Bio-Medicals Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Transasia Bio-Medicals Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Transasia Bio-Medicals Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Transasia Bio-Medicals Ltd, Medical Equipment, Deals By Market, 2011 to YTD 2017 8
Transasia Bio-Medicals Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Transasia Bio-Medicals Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Transasia Enters Into Co-Marketing Agreement With Helena Biosciences 10
Transasia Enters Into Distribution Agreement With Gen-Probe 11
Transasia Enters Into Distribution Agreement With InTec 12
Transasia Enters Into Distribution Agreement Vircell Microbiologists 13
Equity Offering 14
Transasia Bio-Medicals Plans to Raise Funds through IPO 14
Transasia Bio-Medicals Ltd – Key Competitors 15
Transasia Bio-Medicals Ltd – Key Employees 16
Transasia Bio-Medicals Ltd – Locations And Subsidiaries 17
Head Office 17
Other Locations & Subsidiaries 17
Joint Venture 18
Appendix 19
Methodology 19
About GlobalData 19
Contact Us 19
Disclaimer 19

List of Tables
Transasia Bio-Medicals Ltd, Medical Equipment, Key Facts 2
Transasia Bio-Medicals Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Transasia Bio-Medicals Ltd, Medical Equipment, Deals By Year, 2011 to YTD 2017 5
Transasia Bio-Medicals Ltd, Medical Equipment Deals By Type, 2011 to YTD 2017 6
Transasia Bio-Medicals Ltd, Medical Equipment, Deals By Region, 2011 to YTD 2017 7
Transasia Bio-Medicals Ltd, Deals By Market, 2011 to YTD 2017 8
Transasia Bio-Medicals Ltd, Medical Equipment, Deals Summary, 2011 to YTD 2017 9
Transasia Enters Into Co-Marketing Agreement With Helena Biosciences 10
Transasia Enters Into Distribution Agreement With Gen-Probe 11
Transasia Enters Into Distribution Agreement With InTec 12
Transasia Enters Into Distribution Agreement Vircell Microbiologists 13
Transasia Bio-Medicals Plans to Raise Funds through IPO 14
Transasia Bio-Medicals Ltd, Key Competitors 15
Transasia Bio-Medicals Ltd, Key Employees 16
Transasia Bio-Medicals Ltd, Other Locations 17
Transasia Bio-Medicals Ltd, Joint Venture 18

★海外企業調査レポート[Transasia Bio-Medicals Ltd-医療機器分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Phylogica Ltd (PYC):企業の財務・戦略的SWOT分析
    Summary Phylogica Ltd (Phylogica) is a biotechnology company that develops intracellular biological therapeutics. The company utilizes proprietary phylomer peptide libraries and screening methodologies to identify unique peptide drug candidates. Its products include libraries and peptides. Phylogica …
  • Fox Chase Cancer Center-製薬・医療分野:企業M&A・提携分析
    Summary Fox Chase Cancer Center (Fox Chase), formerly American Oncologic Hospital Inc, a subsidiary of Temple University Health System Inc, is a healthcare service provider that offers cancer care services. The center provides screening services for breast, colorectal, prostate, lung and skin cancer …
  • Sygnis AG (LIO1):医療機器:M&Aディール及び事業提携情報
    Summary Sygnis AG (Sygnis), formerly Sygnis Pharma AG is a developer of novel products and tools in the field of molecular biology. The company undertakes development and marketing of new molecular biological technologies for DNA amplification and sequencing. Its offers products such as single cell …
  • Omnicell Inc (OMCL):医療機器:M&Aディール及び事業提携情報
    Summary Omnicell Inc (Omnicell) is a provider of automation and business analytics software solutions. It provides medication control and patient safety solutions to enhance operational efficiency and patient care in acute healthcare facilities. The company offers automation solutions such as medica …
  • Mapi Pharma Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Mapi Pharma Ltd (Mapi Pharma) is a clinical stage pharmaceutical company that offers development of active pharmaceutical ingredients and formulations, and life cycle management products. The company’s lead products include Glatiramer Acetate Depot, an injection for the treatment of multiple …
  • Midland Power Cooperative:企業の戦略的SWOT分析
    Midland Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • China Communications Construction Co Ltd:戦略・SWOT・企業財務分析
    China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Communications Construction Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • DSM Dyneema BV:企業の戦略的SWOT分析
    DSM Dyneema BV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and service …
  • Engie SA (ENGI):企業の財務・戦略的SWOT分析
    Engie SA (ENGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Neuron Biopharma SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Neuron Biopharma SA (NBP) is a biotechnology company that discovers and develops biosolutions. The company offers pharmaceutical compounds to prevent and treat various neurodegenerative diseases. It discovers and assesses nutraceuticals, and development of diagnostic methods for the treatmen …
  • Genzyme Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty care treatments targeting rare diseases, oncology, immunology and multiple sclerosis. It offers products for the treatment of indications including various forms of cancer, mucopolysaccharidosi …
  • Cara Therapeutics Inc (CARA):製薬・医療:M&Aディール及び事業提携情報
    Summary Cara Therapeutics Inc (Cara Therapeutics) is a biotechnology company that develops and commercializes chemical entities for acutepain, chronic pain and pruritus. The company offers kappa opioid receptor agonists in the therapeutic areas of acute pain, chronic pain, neuropathic pain and pruri …
  • Kangwon Land Inc.:企業の戦略・SWOT・財務分析
    Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report Summary Kangwon Land Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Synexus Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Synexus Ltd (Synexus), a subsidiary of Synexus Clinical Research Limited, is a site management organisation that offers patient recruitment and trial management services. The company services include feasibility assessment, project management, patient engagement, patient-centric clinical tri …
  • Concord New Energy Group Ltd (182):企業の財務・戦略的SWOT分析
    Concord New Energy Group Ltd (182) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Edison S.p.A.:企業の戦略・SWOT・財務分析
    Edison S.p.A. - Strategy, SWOT and Corporate Finance Report Summary Edison S.p.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Tecnocom Telecomunicaciones y Energia SA (TEC):企業の財務・戦略的SWOT分析
    Tecnocom Telecomunicaciones y Energia SA (TEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key str …
  • ReShape Medical Inc:医療機器:M&Aディール及び事業提携情報
    Summary ReShape Medical Inc (ReShape Medical), a subsidiary of EnteroMedics Inc is a medical device company that offers weight loss solutions. The company provides dual intragastric balloon for weight loss. Its product comprises of ReShape Duo, a non surgical dual-intragastric balloon used in the tr …
  • Georgetown University:製薬・医療:M&Aディール及び事業提携情報
    Summary Georgetown University (GU) is an academic and research institute that offers educational services. The university provides undergraduate and graduate degree programs in the fields of law, medical, medical residencies, business administration and public policy degrees, post-doctoral positions …
  • Sinphar Pharmaceutical Co Ltd (1734):企業の財務・戦略的SWOT分析
    Sinphar Pharmaceutical Co Ltd (1734) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆